Persistent Long-Term Risk of Liver Related Complications in HCV Patients after Antiviral Therapy - Data from the German Hepatitis C-Registry

Background and aims Direct acting antivirals against hepatitis C improve the short-term outcome of patients with chronic hepatitis C. The long-term clinical course after interferon-free treatment of chronic hepatitis C has rarely been studied in large real-world cohorts. We here present data on 10,448 patients being followed for up to 7 years after DAA therapy in the German Hepatitis C-Registry.